Trial Profile
Cognitive effects of mecamylamine and varenicline in schizophrenia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Mecamylamine (Primary) ; Varenicline (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Pharmacodynamics
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2010 Planned end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Planned end date (Mar 2010) added as reported by ClinicalTrials.gov.